About us Contacts Interactions: 12170
Drug search by name

Canagliflozin and Metformin Extended-Release Tablets and High Cholesterol (Hyperlipoproteinemia, Hypertriglyceridemia, Sitosterolemia)

Result of checking the interaction of Canagliflozin and Metformin Extended-Release Tablets and High Cholesterol (Hyperlipoproteinemia, Hypertriglyceridemia, Sitosterolemia) for safety when used together.

Check result:
Canagliflozin and Metformin Extended-Release Tablets <> High Cholesterol (Hyperlipoproteinemia, Hypertriglyceridemia, Sitosterolemia)
Relevance: 03.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug interaction with food or lifestyle.

Consumer:

There have been reports of dose-related increases in LDL cholesterol with the use of SGLT-2 inhibitors. Cholesterol levels should be monitored before and during treatment and appropriate therapy should be initiated if needed.

Professional:

There have been reports of dose-related increases in LDL cholesterol with the use of SGLT-2 inhibitors. Cholesterol levels should be monitored before and during treatment and appropriate therapy should be initiated if needed.

Canagliflozin and Metformin Extended-Release Tablets

Generic Name: canagliflozin / metformin

Brand Name: Invokamet, Invokamet XR

Synonyms: Canagliflozin and metformin, Canagliflozin and Metformin

CookedMed World